HRTX

Heron Therapeutics, Inc.

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Hensley Mark EarlChief Operating Officer
--136.8k shares
Grant / ExerciseMay 6, 2026
Disclosure amount unavailable125k shares
--
--
Collard Craig ADirector, Officer: Chief Executive Officer
--382.7k shares
Grant / ExerciseApr 30, 2026
Disclosure amount unavailable34.8k shares
--
--
Collard Craig ADirector, Officer: Chief Executive Officer
--750.3k shares
Grant / ExerciseApr 30, 2026
Disclosure amount unavailable50k shares
--
--
Duarte IraEVP, Chief Financial Officer
--128.6k shares
Grant / ExerciseApr 30, 2026
Disclosure amount unavailable11.7k shares
--
--
Duarte IraEVP, Chief Financial Officer
--203k shares
Grant / ExerciseApr 30, 2026
Disclosure amount unavailable13.5k shares
--
--
Forbes William PEVP, Chief Development Officer
--128.6k shares
Grant / ExerciseApr 30, 2026
Disclosure amount unavailable11.7k shares
--
--